747,844 Eye Drops Recalled: Walgreens Brand Over Sterility Fears

The FDA announced a Class II recall of 747,844 eye-care units, including 500,000+ Walgreens-branded products, over sterility concerns.

@sharedot

747,844 Eye Drops Recalled: Walgreens Brand Over Sterility Fears

By @sharedot · · 8 pages

  • Health
  • FDA Recall
  • Eye Drops
  • Walgreens
  • Sterility

The FDA announced a Class II recall of 747,844 eye-care units, including 500,000+ Walgreens-branded products, over sterility concerns.

What Happened: A Massive Eye-Care Recall

Sterling Pharmaceutical Services LLC of Dupo, Illinois, voluntarily initiated the recall on Aug. 20 because of a "lack of assurance of sterility," and the FDA classified it as a Class II action on Sept. 21.

Walgreens-branded items account for the largest share, with roughly 301,114 bottles and 199,600 twin packs of its lubricant eye drops affected. Federal health officials expanded the recall on Sept. 29, adding additional lots for several brands.

The Full Recall List, Brand by Brand

Beyond Walgreens, the recall covers products sold under AvKare, Reliable-1 Laboratories, Cameron Pharmaceuticals, TRP The Relief Products and Major brand names.

According to LiveNOW from FOX, the affected products include 19,284 bottles of Cameron Pharmaceuticals Carboxymethylcellulose Sodium 0.5% Eye Lubricant, more than 120,000 AvKare lubricant eye drop packs, 11,083 bottles of Reliable-1 Sodium Chloride Hypertonicity Ophthalmic Solution 5%, 47,616 bottles of Reliable-1 Lubricating Tears, 14,538 bottles of TRP Gentle Eyes Lubricant Eye Drops and 34,368 tubes of Major LubriFresh P.M.

Nighttime Ointment.

Why a Class II Designation Matters

The FDA's Class II classification signals that use of or exposure to the affected products may cause temporary or medically reversible adverse health consequences, while the probability of serious health consequences is considered remote.

That framing, reported by Fox Business and the Daytona Beach News-Journal, means regulators see a genuine quality failure without evidence so far of severe harm. No injuries tied to this particular recall have been confirmed.

Why Sterile Eye Drops Are Non-Negotiable

The FDA says ophthalmic products pose a heightened risk because drugs applied directly to the eyes bypass some of the body's natural defenses, so eye drops must be sterile to reduce the risk of infection.

Hoodline notes the caution traces to a 2023 outbreak of drug-resistant Pseudomonas aeruginosa linked to EzriCare Artificial Tears, which caused four deaths, 14 cases of vision loss and more than 80 infections nationwide.

Hoodline also reports that Sterling received an FDA Warning Letter in September 2022 after a February 2022 inspection found inadequate environmental air monitoring in sterile processing rooms and unvalidated aseptic procedures, and that the company concurrently recalled 57,848 packs of Puralube Vet Ointment, a pet eye lubricant made at the same facility.

A Pattern of 2026 Eye Drop Recalls

Sterling's action is the latest in a string of eye drop recalls this year. Hoodline reports a 3.1-million-bottle recall in April after California manufacturer K.C.

Pharmaceuticals pulled private-label drops across 26 brand labels, including Walgreens, CVS and Kroger, over sterility concerns, and a July recall of more than 39,000 bottles of Clear Eyes Maximum Itchy Eye Relief by Medtech Products over a single manufacturing lot.

LiveNOW from FOX adds that on Aug. 1, nearly 12 million bottles of Rohto eye drops were recalled, also over sterility concerns.

What Consumers Should Do Now

Consumers who use any of the affected products should check the product name, lot number and expiration date on the packaging and compare those details with the FDA enforcement report at accessdata.fda.gov, since lot numbers vary by brand and package size.

If a product matches the recalled lot information, the FDA advises stopping use immediately and contacting a health care provider.

Anyone who used a recalled product and experiences pain, redness, discharge or vision changes should seek prompt clinical evaluation and tell the provider which product was used. A Walgreens representative did not immediately respond to Fox Business' request for comment.

Sources

  1. foxbusiness.com › Popular eye drops sold at Walgreens recalled over sterility concerns
  2. livenowfox.com › Eye drops recall: Bottles sold under several brand names may not be sterile, FDA says
  3. ntd.com › More Than 700,000 Eye Drop Products Recalled Over Sterility Concerns
  4. news-journalonline.com › Eye drops recalled for Walgreens brands. What you should check
  5. hoodline.com › Walgreens Eye Drops Among 747,844 Units Recalled Over Sterility Fears

More on Health